InvestorsHub Logo
Followers 0
Posts 72
Boards Moderated 0
Alias Born 04/28/2021

Re: None

Wednesday, 02/01/2023 11:00:00 AM

Wednesday, February 01, 2023 11:00:00 AM

Post# of 53506
$CYBN Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004. This is the first trial ever evaluating deuterated DMT in humans! https://ir.cybin.com/investors/news/news-details/2023/Cybin-Announces-Approval-of-First-in-Human-Dosing-of-its-Proprietary-DMT-Molecule-CYB004/default.aspx

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.